Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438328
Filing Date
2013-11-12
Accepted
2013-11-12 16:29:49
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d593094d10q.htm 10-Q 542514
2 EX-31.1 d593094dex311.htm EX-31.1 9387
3 EX-31.2 d593094dex312.htm EX-31.2 9418
4 EX-32.1 d593094dex321.htm EX-32.1 4407
5 EX-32.2 d593094dex322.htm EX-32.2 4316
  Complete submission text file 0001193125-13-438328.txt   3023556

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT achn-20130930.xml EX-101.INS 320592
7 XBRL TAXONOMY EXTENSION SCHEMA achn-20130930.xsd EX-101.SCH 30500
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achn-20130930_cal.xml EX-101.CAL 42895
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achn-20130930_def.xml EX-101.DEF 190092
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE achn-20130930_lab.xml EX-101.LAB 243814
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achn-20130930_pre.xml EX-101.PRE 224805
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33095 | Film No.: 131210543
SIC: 2834 Pharmaceutical Preparations